Since the first anatomic description of hypertrophic cardiomyopathy (HCM) in 1958, significant advancements have expanded the understanding of this condition. At the same time, new imaging tools and treatment modalities have contributed to an ever-changing armamentarium for the assessment and treatment of patients with HCM. The historical perspective of HCM discovery and the progress made in the last several decades shed light on the road still ahead, which is expected to lead to better forms of treatment and perhaps even prevention of this, at times, devastating disease.
Keywords: Alcohol septal ablation; Genetics; Hypertrophic cardiomyopathy; Implantable cardioverter-defibrillator; Septal myectomy.
Copyright © 2018 Elsevier Inc. All rights reserved.